Prof Martin Dreyling opened the symposium by providing an overview of the current status of mantle cell lymphoma (MCL) and the current guidelines for treatment. Prof Steven Le Gouill discussed emerging tools to improve the diagnosis and monitoring of patients such as the assessment of minimal residual disease and the optimal incorporation of new technologies into the treatment pathway. Prof Marek Trněný then spoke about new treatment options for MCL and the improved survival that has been reported from certain combination therapies. Prof Martin Dreyling closed the MCL session.
Prof Gilles Salles introduced the follicular lymphoma (FL) session by explaining how the treatment landscape of FL has recently changed with the advent of anti-CD20 therapies. Prof Paulo Corradini then described the current treatment landscape in FL and Dr Jehan Dupuis spoke about the use of positron emission tomography (PET) at the start, interim, and end of treatment for FL. Prof Gilles Salles described the challenges of incorporating new treatment recommendations and tools for FL within current treatment options, and then summarised and closed the event.
Please view the full content in the pdf above.